Heparan sulphates
US-10266612-B2 · Apr 23, 2019 · US
US10493012B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10493012-B2 |
| Application number | US-201515527995-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 19, 2015 |
| Priority date | Nov 19, 2014 |
| Publication date | Dec 3, 2019 |
| Grant date | Dec 3, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Affinity purification of fibroblast growth factor 2-binding heparan sulphate from porcine mucosa (HS8) is disclosed. Also disclosed is a process for the care of keratinous material(s), comprising the application or administration of HS8, or a composition comprising thereof, to keratinous material(s). The composition may be used to improve the condition of skin, such as smoothing the skin, restoring skin elasticity and firmness, or decreasing or preventing wrinkles, and may be formulated for topical or transdermal administration.
Opening claim text (preview).
The invention claimed is: 1. A cosmetic process for caring for keratinous material(s), the process comprising application or administration of heparan sulphate HS8, or a composition comprising heparan sulphate HS8, to keratinous material(s), wherein the heparan sulphate HS8 is capable of binding a peptide or polypeptide having, or consisting of, the amino acid sequence YCKNGGF (SEQ ID NO:2) or GHFKDPKRLYCKNGGF (SEQ ID NO:1). 2. The process of claim 1 , wherein the keratinous material(s) is selected from one or more of human skin, hair or nails. 3. The process of claim 1 , wherein heparan sulphate HS8 is used or is present in the composition in a content ranging from 0.0001% to 5% by weight, relative to the total weight of the composition. 4. The process of claim 1 , wherein said process is intended to decrease the signs of ageing of the keratinous material(s). 5. The process of claim 1 , wherein said process is intended to maintain and/or stimulate moisturization and/or combat drying-out of the keratinous material(s). 6. The process of claim 2 , wherein said process is intended to: (i) decrease characteristics of wrinkles, small wrinkles and/or fine lines of the skin; (ii) improve and/or decrease the microrelief of the skin; (iii) smooth the skin; (iv) improve the density of the skin; (v) maintain and /or restore skin elasticity; (vi) maintain and/or restore skin firmness; or (vii) maintain and/or restore the cohesion of skin compartments. 7. A cosmetic method of regulating a skin condition, comprising applying or administering to the skin of a human individual a safe and effective amount of heparan sulphate HS8, or a composition comprising heparan sulphate HS8, wherein the heparan sulphate HS8 is capable of binding a peptide or polypeptide having, or consisting of, the amino acid sequence YCKNGGF (SEQ ID NO:2) or GHFKDPKRLYCKNGGF (SEQ ID NO:1). 8. The cosmetic method of claim 7 wherein the method comprises improving skin appearance and/or feel. 9. The cosmetic method of claim 7 , wherein the method comprises regulating visible and/or tactile discontinuities in skin texture. 10. The process of claim 1 wherein the heparan sulphate HS8 is provided in isolated or substantially purified form. 11. The process of claim 1 wherein following digestion with heparin lyases I, II and Ill and then subjecting the resulting disaccharide fragments to capillary electrophoresis analysis the heparan sulphate HS8 has a disaccharide composition comprising: Disaccharide Normalised weight percentage ΔUA,2S-GlcNS,6S 12.7 ± 3.0 ΔUA,2S-GlcNS 7.2 ± 2.0 ΔUA-GlcNS,6S 15.5 ± 3.0 ΔUA,2S-GlcNAc,6S 6.5 ± 2.0 ΔUA-GlcNS 15.7 ± 3.0 ΔUA,2S-GlcNAc 1.0 ± 0.5 ΔUA-GlcNAc,6S 8.9 ± 3.0 ΔUA-GlcNAc 32.5 ± 3.0.
Polysaccharides · CPC title
Anti-ageing preparations · CPC title
General cosmetic use · CPC title
Preparations for dry skin · CPC title
Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.